This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: The Innovative Journey of Chakra Ravi Turaga
Introduction
Chakra Ravi Turaga is an accomplished inventor based in Atlanta, GA (US). She has made significant contributions to the field of biotechnology, particularly in the development of non-toxic anti-angiogenesis proteins. Although she currently holds no granted patents, her work is noteworthy for its potential impact on cancer treatment.
Latest Patent Applications
Chakra Ravi Turaga's latest patent application is titled "Integrin-Targeting Protein and Methods of Use Thereof." This application describes a non-toxic anti-angiogenesis protein that inhibits tumor growth. The protein exhibits in vitro activity in inducing angiogenic endothelial cell apoptosis without targeting VEGF/VEGFR or any other RTK pathways. It specifically targets integrins αβ, at a groove in the βA domain of β formed by the α2 helix, B-C loop, and α2-α3 loop.
Conclusion
Chakra Ravi Turaga's innovative work in biotechnology highlights her commitment to advancing cancer treatment through her research and applications. Her contributions, although not yet reflected in granted patents, demonstrate her potential to make a significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile